Regenerative medicine (RM) is one of the most promising fields of regenerative medicine, with regenerative ophthalmology (RO) being one of the most active domains. The ability of revolutionary therapies to treat a number of disorders, ranging from AMD to congenital degenerations, is being explored. Regenerative ophthalmology (RO) strives to restore function by employing biomaterials, cells, and bioactive substances to replace or regenerate tissues and organs. These unique therapeutic techniques have the potential to improve the effectiveness and efficiency of ocular disease management. With the advancement of tissue engineering tools, RO researchers have focused their attention on the regeneration of lost or injured eye tissues as a new way to cure visual impairment and blindness caused by ocular degenerative disorders, trauma, or infection.
Title : Eyes and guts connection: Microbiomes and their role in ocular health
Edward Charles Kondrot, Healing the Eye Wellness Center, United States
Title : Optic nerve orthograde axonal transport in abusive head trauma suspects
Minckler Don S, UCI Gavin Herbert Eye Institute, United States
Title : Why was Leonhard Euler blind?
John David Bullock, Wright State University, United States
Title : A factorial randomized controlled trial of tissue plasminogen activator and/or perfluoropropane for the treatment of submacular hemorrhage secondary to neovascular age-related macular degeneration (TAPAS)
Tim Jackson, King’s College London, United Kingdom
Title : Monovision cataract surgery made simple
Shadrokh Nabili, University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom
Title : An innovative in vitro human-based millifluidic platform as useful tool to underlying mechanisms of neurodegeneration in glaucoma
Anna Maria Bassi, University of Genoa, Italy